Skip to Main Content

Paper Details

Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.
Cell
56
2021
CD8+, CD8+ T cell, CD8+ T cell epitopes, CoV, CoV-2, HLA class I, HLA class I peptide, SARS, SARS-, SARS-CoV-2, SARS-like coronaviruses, T, alleles, mRNA, mutationally constrained regions, sarbecoviruses, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Elizabeth J RossinThe Broad Institute, USA Harvard Medical School Department of Ophthalmology
Ryan J ParkRagon Institute of MGH
Dylan KoundakjianRagon Institute of MGH
Nishant K SinghRagon Institute of MGH, USA Koch Institute for Integrative Cancer Research at MIT
Alicja TrochaRagon Institute of MGH, USA Howard Hughes Medical Institute
Alicja TrochaRagon Institute of MGH, USA Howard Hughes Medical Institute
Wilfredo F Garcia-BeltranRagon Institute of MGH, Massachusetts General Hospital
Anthony J IafrateMassachusetts General Hospital
Vivek NaranbhaiMassachusetts General Hospital, USA Dana-Farber Cancer Institute, USA Center for the AIDS Programme of Research in South Africa
Mary CarringtonRagon Institute of MGH, Frederick National Laboratory for Cancer Research in the Laboratory of Integrative Cancer Immunology, National Cancer Institute
Mary CarringtonRagon Institute of MGH, Frederick National Laboratory for Cancer Research in the Laboratory of Integrative Cancer Immunology, National Cancer Institute
Bruce D WalkerRagon Institute of MGH, USA The Broad Institute, USA Howard Hughes Medical Institute, USA Center for the AIDS Programme of Research in South Africa, South Africa Institute for Medical Engineering and Science and Department of Biology, Massachusetts Institute of Technology
Bruce D WalkerRagon Institute of MGH, USA The Broad Institute, USA Howard Hughes Medical Institute, USA Center for the AIDS Programme of Research in South Africa, South Africa Institute for Medical Engineering and Science and Department of Biology, Massachusetts Institute of Technology
  • 1 - 13

Datasets